ISPOR ANNOUNCES NEW 2017 HEALTH ECONOMICS AND OUTCOMES RESEARCH TRAINING PROGRAMS

Published Dec 5, 2016
Princeton, NJ—December 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced  its upcoming health economics and outcomes research (HEOR) in-person training programs scheduled for early 2017.   ISPOR Health Technology Assessment (HTA) Training Program 20-23 February 2017 | Bogotá, Colombia The ISPOR Health Technology Assessment (HTA) Training Program is designed “HTA users and doers” in government in addition to public and private payers, industry, health plans, academia, and patient group representatives interested in learning how to conduct various aspects of HTA with an emphasis on clinical and economic evaluation. Program faculty includes Finn Børlum Kristensen, MD, PhD, Manuel Espinoza, MD, MSc, PhD, and Aurelio Mejía, MSc, BSc. Additional information on the training can be found here. Essential Elements of Pricing Training Program March 9-10, 2017 | Philadelphia, PA, USA The Essential Elements of Pricing Training Program educates attendees on the context, rules, and processes behind pharmaceutical pricing in addition to an overview of the tradeoffs, commonalities, and differences between markets and disease areas. Faculty for the program includes, Jack Mycka and Renato Dellamano. Additional information can be found here. Introduction to Health Economics and Outcomes Research Training Program April 6-7, 2017 | San Francisco, CA, USA The Introduction to Health Economics and Outcomes Research (HEOR): Principles and Practice in Health Care Decision Making Training Program. Provides participants with the essential skills required to perform and critique health care economic studies and models to determine cost-effective medications, devices, and interventions. This training will be led by Lorne E. Basskin, PharmD. Program information can be found here. Additional information on ISPOR In-Person Training Programs can be found here and details on the ISPOR HTA Training Program can be found here.

###

 

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×